Best Growth Stock Screener: US and European Filters

Growth stock screening is fundamentally different from value screening. A value investor looks for cheap stocks; a growth investor looks for companies compounding revenue and earnings at above-average rates — and is willing to pay a premium for that compounding. The screening criteria are different, the thresholds are different, and the risk of mistakes is different.

This guide explains how to screen for growth stocks, which metrics matter most, and which screener handles the workflow best.

Last updated: July 2026.

What makes a stock a growth stock?

A growth stock is a company growing its revenue and/or earnings significantly faster than the broad market. There is no universally agreed definition, but growth investors typically look for:

• Revenue growth above 15–20% annually — well above the 5–8% typical for mature businesses
• Expanding margins — revenue growth that comes with operating leverage (margins improving as the business scales)
• High ROIC or ROE — the business earns strong returns on the capital it deploys
• Large addressable market — room to grow before hitting saturation
• Sustainable competitive advantage — a reason why the growth won't be competed away immediately

Growth stocks often trade at high P/E ratios — 25×, 40×, or more — because investors are paying for expected future earnings, not current earnings. This is not automatically overvaluation; if the company continues compounding at 25% annually, a high P/E can be justified. The risk is when growth slows and the premium collapses.

Growth stock screening metrics: what to filter on

Revenue growth (the primary signal)

Revenue growth is the most direct measure of a growth business. For a traditional growth stock screen, look for:

• Trailing 12-month revenue growth > 15% — basic growth threshold
• 3-year revenue CAGR > 15% — confirms the growth is sustained, not a one-quarter spike
• Sequential quarterly growth (where available) — shows the growth trajectory is still accelerating

A company growing revenue at 30% for three consecutive years is a more reliable growth candidate than one that grew 100% in one year on a low base and then stalled.

Operating leverage (margin expansion)

Revenue growth alone is necessary but not sufficient. The best growth businesses demonstrate operating leverage — margins expand as the business scales, because fixed costs are spread over a larger revenue base.

Filters to identify operating leverage:

• Operating margin trending positive — margin this year higher than last year
• Gross margin > 40% — high gross margin leaves room for margin expansion as the company scales
• Net margin turning positive (for earlier-stage growth companies) — the business is approaching or crossing profitability

A company growing revenue at 25% with expanding margins is a high-quality growth candidate. A company growing at 25% with flat or declining margins is burning cash to buy growth — a fundamentally different risk profile.

Return on Invested Capital (ROIC)

For established growth companies (not early-stage), ROIC above the cost of capital is the key signal of quality growth. A company that earns 25% ROIC and reinvests profits back into the business at 25% return is compounding intrinsic value at a rate that justifies a premium valuation.

• ROIC > 15% — good quality growth
• ROIC > 25% — exceptional quality; the business has genuine competitive advantage
• ROIC consistently above 15% for 3+ years — confirms durability, not a one-year spike

Growth companies with high ROIC are the stocks associated with the best long-term compounding returns. See also: ROIC Investing Guide.

PEG ratio (growth-adjusted P/E)

The PEG ratio (P/E divided by earnings growth rate) adjusts the P/E for growth speed. A P/E of 30 for a company growing earnings at 30% gives a PEG of 1.0 — which many growth investors consider fair value. A PEG below 1.0 suggests the growth is underpriced relative to the P/E.

• PEG < 1.0 — potential undervaluation relative to growth
• PEG 1.0–2.0 — fair to moderately expensive for the growth rate
• PEG > 2.5 — pricing in a lot of future growth; requires high confidence in the trajectory

The PEG ratio is most useful as a relative comparison tool between similar growth companies — not an absolute threshold.

Balance sheet health

Growth investing carries an inherent risk: the company may need capital to fund its growth. Companies that fund growth through external capital (equity issuance, debt) rather than organic free cash flow are more vulnerable to market disruptions.

Filter for:

• Debt/Equity < 1.0 — limited financial leverage; growth is not debt-funded
• Current ratio > 1.5 — adequate short-term liquidity
• Free cash flow positive (for companies beyond the early growth phase) — the business generates cash, it doesn't consume it

Practical growth stock screens

Screen 1 — Established growth (profitable compounders)

For investors looking for growth companies that are already profitable and demonstrating operating leverage.

This screen targets companies that are growing fast enough to qualify as growth but are already profitable. This excludes early-stage hypergrowth companies that may be burning cash — and eliminates many of the traps in pure growth screening.

Typical results across US + European markets: 200–400 companies. Sort by revenue growth descending to find the fastest growers at the top; sort by P/E ascending to find the cheapest growers.

Screen 2 — High-quality growth (ROIC-focused)

For investors who want the highest-quality growth businesses — those generating exceptional returns on capital that justify premium valuations.

This is a narrower screen — it will return fewer companies, but the quality bar is higher. The businesses surfaced here are typically ones with strong competitive moats: pricing power, recurring revenue models, or network effects.

Typical results: 100–200 companies. The top results by revenue growth are typically the most compelling starting points.

Screen 3 — Emerging growth (pre-profitability, scaling)

For investors comfortable with earlier-stage growth companies that aren't yet consistently profitable.

This screen targets companies growing fast enough to potentially reach profitability soon, with gross margins high enough to suggest the business model works at scale. High gross margin (>40%) for a pre-profit company suggests the losses are from investment (sales, R&D), not from a structurally uneconomic business model.

Important: This screen will surface many speculative companies alongside genuine opportunities. Every result requires deeper diligence — understanding the unit economics, the path to profitability, and the competitive moat.

Growth stock screening by geography

Growth stocks are not evenly distributed across markets:

US markets (NYSE, NASDAQ): The deepest pool of technology and healthcare growth stocks globally. The US has the most growth companies by count and the most data coverage. Finviz covers US growth stocks well on its free tier; ScreenerHero covers US markets too.

European growth stocks: Concentrated in Nordic tech (Nasdaq Stockholm, Nasdaq First North), German software and industrial tech (XETRA), and French technology (Euronext Growth Paris). European growth stocks are systematically undercovered by most screeners — fundamental data for Euronext Growth and First North companies is often missing or stale on tools not built specifically for European coverage.

Canadian markets (TSX, TSXV): Mining and resources dominate, but the TSX also has a growing technology sector, particularly in financial technology and software.

ScreenerHero covers all three geographies in a single screening interface — the only free-tier tool that does this for systematic growth screening.

Common mistakes in growth stock screening

Mistake 1 — Confusing revenue growth with earnings growth. A company can grow revenue 40% while its earnings fall. High revenue growth funded by heavy investment (sales, R&D, infrastructure) doesn't automatically create shareholder value. Combine revenue growth with margin direction to distinguish real growth businesses from growth-funded-by-capital-destruction.

Mistake 2 — Ignoring the dilution question. Growth companies frequently issue shares to fund expansion. Share issuance grows the pie — but if it grows it faster than earnings, earnings per share (EPS) growth lags revenue growth, and the investor's per-share economics are worse than the revenue line suggests. Screen for EPS growth, not just revenue growth.

Mistake 3 — Buying growth at any price. The PEG ratio exists for a reason. A company growing at 20% trading at P/E 80 (PEG of 4.0) requires that growth to accelerate significantly just to justify the current price. High growth at a reasonable price is different from high growth at an extreme price.

Mistake 4 — Ignoring sector cyclicality. "Growth" in cyclical industries (energy, mining, commodities) is often driven by price cycles, not structural demand growth. A mining company whose revenue grew 80% because commodity prices doubled is not a growth company — it's a commodity cyclical. Filter for sectors where growth is structural rather than price-driven.

Mistake 5 — Treating the screener output as a buy list. A growth screen produces candidates — not investments. After the screen, the work is understanding why the company is growing, whether that growth is sustainable, and what the competitive dynamics look like. Screeners find candidates; judgment makes the decision.

Which screener is best for growth stocks?

Data as of June 2026.

For investors screening US growth stocks exclusively: Finviz is excellent and free. For European growth stocks — especially the technology companies on Euronext Growth Paris and Nasdaq First North — ScreenerHero is the only screener with comprehensive coverage and reliable fundamental data.

Frequently asked questions

What P/E ratio is considered high for a growth stock?

There is no universal threshold — it depends entirely on the growth rate. A P/E of 40 for a company growing earnings at 40% (PEG of 1.0) is considered fair by many growth investors. A P/E of 40 for a company growing at 10% (PEG of 4.0) is expensive. The PEG ratio provides more context than absolute P/E level when evaluating growth stocks.

How is growth investing different from momentum investing?

Growth investing selects companies based on fundamental business growth — revenue, earnings, and returns on capital. Momentum investing selects companies based on recent price performance — stocks that have gone up tend to continue going up in the short term. A growth company may have weak price momentum while fundamentals are still strong; a momentum stock may have no fundamental growth story but strong recent price action. The two approaches overlap but are conceptually distinct.

Should I include pre-revenue or pre-profit companies in a growth screen?

This depends on your risk tolerance. Pre-profit growth companies (growing revenue fast but not yet profitable) carry significantly higher risk than profitable ones — the path to profitability is uncertain, capital needs are unpredictable, and valuations can collapse if growth slows. Most individual investors are better served by the "established growth" or "high-quality growth" screens above, which require positive operating margins. Pre-profit screening is better suited to investors who can do thorough unit economics analysis for each candidate.

How often should I rerun a growth stock screen?

Monthly at minimum; quarterly is sufficient for most strategies. Growth stock fundamentals update quarterly with earnings reports — a company that was a growth candidate six months ago may have slowed significantly. Regular rerunning catches both new entrants (companies that have accelerated) and exits (companies whose growth has decelerated below your threshold).

Can I find growth stocks in Europe?

Yes — European markets have genuine growth companies, particularly in Nordic tech (Sweden, Denmark, Finland via Nasdaq First North), German software and business services, and French technology (Euronext Growth Paris). European growth stocks are systematically less covered than US ones — which creates pricing inefficiency. The challenge is data: most screeners have poor fundamental data for European growth companies below large-cap. ScreenerHero covers European growth markets including alternative exchanges with reliable revenue growth and margin data.

Related guides

• ROIC Quality Investing Guide — screening for the highest-quality compounders by return on invested capital
• GARP Investing in Europe — growth at a reasonable price, balancing growth and valuation
• Best European Stock Screener — full comparison of tools for European equity screening
• Momentum Investing in Europe — price momentum as a complement to growth screening
• Quality Investing in Europe — quality-focused screening strategies for European equities
• Best Stock Screener for Growth Investors — tool-by-tool comparison for growth screening specifically

Open the growth stock screener → — free, no account required. Filter US, Canada, and European stocks by revenue growth, ROE, operating margin, and more. Pro at $29/month.